This limited competition funds a 3-year extension of the COPE-AKI clinical trial consortium, including clinical centers and a scientific data research center. The award supports completing enrollment, participant follow-up, data analysis, and dissemination of findings to inform improved clinical management and standard care development for Stage 2 and 3 acute kidney injury survivors.
Only current recipients under RFA-DK-20-011, specifically the institutions employing the original COPE-AKI Clinical Centers and Scientific Data Research Center PIs, are eligible. Foreign organizations and components are not eligible.